Company page

Sagimet Biosciences Inc. - Series A

Sagimet Biosciences Inc. is a public company traded under the ticker SGMT on the American market, with a market capitalization of approximately $408.7 million. The company focuses on developing innovative therapies in the field of biosciences. As a Series A company, Sagimet is positioned to advance its research and development initiatives.